Prevalence of thrombophilia in patients with severe ovarian hyperstimulation syndrome;Prevalence trombofilií u pacientek s těžkou formou ovariálního hyperstimulačního syndromu

Ceska Gynekologie

Volumn 70, Issue 4, 2005, Pages 254-257

  Machač, Štěpán ^a   Prochazka M ^b   Lubusky M ^b  

^a Klinika pro lécbu neplodnosti a zenských nemocí Unica   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Factor V Leiden mutation; Ovarian hyperstimulation syndrome; Thrombophilia

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S;

ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; HUMAN; OVARY HYPERSTIMULATION; PREVALENCE; RETROSPECTIVE STUDY; THROMBOPHILIA;

EID: 23244438312     PISSN: 12107832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Alfirevic, Z., Mousa, H. A., Martlew, V., et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet. Gynecol., 2001, 97, p. 753-759.
2. Alfirevic, Z., Roberts, D., Martlew, V., et al. How strong is the association between maternal thrombophilia and reverse pregnancy outcome? A systematic review. Eur. J. Obst. Gynecol. Reprod. Biol., 2002, 101, p. 6-14.
3. Arya, R., Shehata, A. H., Patel, R. K., et al. Internal jugular vein thrombosis after assisted conception therapy. Brit. J. Haem., 2001, 115, p. 153-155.
4. Biron, CH., Galtier-Dereure, F., Robesandratena, H., et al. Hemostasis parameters during ovarian stimulation for in vitro fertilisation: results of a prospective study. Fertil. Steril., 1997, 67, s. 104-109.
5. Brinsden, P. R., Wada, I., Tan, S. L., et al. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Brit. J. Obstet. Gynecol., 1995, 102, p. 767-772.
6. Dulitzki, M., Cohen, S. B., Inbal, A., et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil. Steril., 2002, 77, p. 463-467.
7. Fabregues, F., Tassies, D., Reverte, J. C., et al. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fertil. Steril, 2004, 81, p. 989-995.
8. Lindquist, P., Dählback, B., Marsal, K. Thrombotic risk during pregnancy: A population study. Obstet. Gynecol., 1999, 94, p. 595-599.
9. Navot, D., Bergh, P., Leufer, N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil. Steril., 1992, 58, p. 249-261.
10. Paseka, J., Unzeitig, V., Cibula, D., et al. Mutace faktoru V Leiden u uživatelek hormonální antikoncepce. Čes. Gynek., 2000, 65, p. 156-159.
11. Tsanadis, G., Yartholomatos, G., Korkontzelos, I., et al. Polycystic ovarian syndrome and thrombophilia. Hum. Repr., 2002, 17, p. 314-319.